Next-generation anti–Staphylococcus aureus vaccines: A potential new therapeutic option for atopic dermatitis? - 04/01/19
Doi : 10.1016/j.jaci.2018.08.038
Julianne Clowry, MB a, b, c, Alan D. Irvine, MD, DSc a, b, c, ⁎ 
, Rachel M. McLoughlin, PhD d, ⁎
, Rachel M. McLoughlin, PhD d, ⁎ a Pediatric Dermatology, Our Lady's Children's Hospital Crumlin, Dublin, Ireland
b National Children's Research Centre, Our Lady's Children's Hospital Crumlin, Dublin, Ireland
c Clinical Medicine, Trinity College Dublin, Dublin, Ireland
d Host-Pathogen Interactions Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Dublin, Ireland
∗Corresponding authors: Alan D. Irvine, MD, DSc, Our Lady's Children's Hospital Crumlin, Dublin, Ireland.Our Lady's Children's Hospital CrumlinDublinIreland∗∗Rachel M. McLoughlin, PhD, Host-Pathogen Interactions Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, DublinHost-Pathogen Interactions GroupSchool of Biochemistry and ImmunologyTrinity Biomedical Sciences InstituteDublin
Key words : Staphylococcus aureus, atopic dermatitis, vaccine, T cell
Le texte complet de cet article est disponible en PDF.
| Research in the lab is supported by a Science Foundation Ireland Investigator Award (15/IA/3041; to R.M.M.). |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2018
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 143 - N° 1
P. 78-81 - janvier 2019 Retour au numéro
Article précédent
- News Beyond Our Pages
- Marc E. Rothenberg, Jean Bousquet
- Controversies in drug allergy: Consensus documents from the world experts
- Michael Schatz, Alessandro Fiocchi, Erika Jensen-Jarolim, Zuhair K. Ballas
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?